| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/29/1998 | WO1998003534A1 Calcitonin gene-related peptide receptor component factor (houdc44) |
| 01/29/1998 | WO1998003206A1 The butyrophilin gene promoter and uses thereof |
| 01/29/1998 | WO1998003200A2 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease |
| 01/29/1998 | WO1998003199A1 Polynucleotide vaccine formula for treating dog diseases, particularly respiratory and digestive diseases |
| 01/29/1998 | WO1998003198A1 Polynucleotide vaccine formula for treating horse diseases |
| 01/29/1998 | WO1998003197A1 Env-glycoprotein vaccine for protection of htlv-i and -ii infection |
| 01/29/1998 | WO1998003189A1 Use of conantokins |
| 01/29/1998 | WO1998003060A1 Hepatitis c model animals |
| 01/29/1998 | WO1998003059A1 Galanin |
| 01/29/1998 | WO1997047732A3 Hexameric fusion proteins and uses therefor |
| 01/29/1998 | WO1997044463A3 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin |
| 01/29/1998 | WO1997041234A3 PROTEINS INVOLVED IN THE SYNTHESIS AND ASSEMBLY OF O-ANTIGEN IN $i(PSEUDOMONAS AERUGINOSA) |
| 01/29/1998 | DE19732136A1 Gefrorenes Nahrungsmittelprodukt A frozen food product |
| 01/29/1998 | DE19732132A1 Gefrorenes Nahrungsmittelprodukt A frozen food product |
| 01/29/1998 | DE19630557A1 Gewebe-Transglutaminase (EC 2.3.13, tTG), in der Eigenschaft als Autoantigen der einheimischen Sprue/Zöliakie, welches spezifisch durch Antikörper aus Seren von Patienten mit einheimischer Sprue erkannt wird; Tissue transglutaminase (EC 2.3.13, tTG), in its capacity as autoantigen of celiac local / celiac disease, which is specifically recognized by antibodies from sera of patients with endemic sprue; deren Verwendung in Diagnostik, Therapiekontrolle und Therapie der Sprue, sowie anderer Erkrankungen/Symptome, die mit einer Immunreaktion gegen die tTG einhergehen their use in diagnosis, therapy monitoring and treatment of celiac disease, and other diseases / symptoms associated with an immune reaction against tTG |
| 01/29/1998 | DE19630390A1 Proteine, insbesondere Membranproteine von Helicobacter pylori, ihre Herstellung und Verwendung Proteins, especially membrane proteins from Helicobacter pylori, their preparation and use |
| 01/29/1998 | CA2262008A1 Bivalent agonists for g-protein coupled receptors |
| 01/29/1998 | CA2262007A1 Env-glycoprotein vaccine for protection of htlv-i and -ii infection |
| 01/29/1998 | CA2261570A1 Use of conantokins |
| 01/29/1998 | CA2261568A1 Conantokins |
| 01/29/1998 | CA2261566A1 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| 01/29/1998 | CA2261343A1 Avian polynucleotide vaccine formula |
| 01/29/1998 | CA2261016A1 Deformylation of f-met peptides in bacterial expression systems |
| 01/29/1998 | CA2260767A1 Fas ligand-like protein, its production and use |
| 01/29/1998 | CA2260763A1 Melatonin 1a receptor gene regulatory regions and uses thereof |
| 01/29/1998 | CA2260752A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways |
| 01/29/1998 | CA2260748A1 Human osteoclast-specific and -related dna sequences |
| 01/29/1998 | CA2260745A1 A novel galanin receptor |
| 01/29/1998 | CA2260287A1 Method of increasing growth and yield in plants |
| 01/29/1998 | CA2260020A1 The butyrophilin gene promoter and uses thereof |
| 01/29/1998 | CA2236036A1 Signal-regulated, cleavage-mediated toxins |
| 01/29/1998 | CA2232741A1 Chemically-inducible arabidopsis pr-1 promoter |
| 01/29/1998 | CA2232142A1 Cd6 ligand |
| 01/28/1998 | EP0821238A2 Method and kit for confirming in vitro the diagnosis of the coeliac disease |
| 01/28/1998 | EP0821237A2 Immunoassay for detection of anti-B. burgdorferi antibodies and method for serological detection of lyme borreliose, diagnostic agent and test kits for carrying out the methods |
| 01/28/1998 | EP0821061A2 Calcitonin gene-related peptide receptor component factor (houdc44) |
| 01/28/1998 | EP0821060A2 Diagnosis and therapy of human malign tumors based on E-cadherin mutations |
| 01/28/1998 | EP0821007A2 Aprotinin variants with improved properties |
| 01/28/1998 | EP0821006A2 Derivatives of insulin having enhanced zinc binding activity |
| 01/28/1998 | EP0821005A2 Preparation of an interferon-gamma inducing polypeptide |
| 01/28/1998 | EP0821003A1 Peptides and remedy for autoimmune diseases comprising the same |
| 01/28/1998 | EP0820598A1 Assaying protein fragments in body fluids |
| 01/28/1998 | EP0820590A1 Novel protein from dirofilaria immitis and method for immunodiagnosis of heartworm in mammals |
| 01/28/1998 | EP0820526A1 Coding sequences of the human brca1 gene |
| 01/28/1998 | EP0820523A1 Conserved yeast nucleic acid sequences |
| 01/28/1998 | EP0820512A1 New chemokine expressed in eosinophils |
| 01/28/1998 | EP0820511A1 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas |
| 01/28/1998 | EP0820510A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors |
| 01/28/1998 | EP0820509A1 Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides |
| 01/28/1998 | EP0820507A1 Ndf peptides |
| 01/28/1998 | EP0820489A1 Hybrid phthalocyanine derivatives and their uses |
| 01/28/1998 | EP0820469A1 Identification, purification and uses of leczymes and carbohydrate ligands |
| 01/28/1998 | EP0820468A1 Process for the purification of glycoproteins like erythropoietin |
| 01/28/1998 | EP0820467A1 Methods of treating disorders of the eye |
| 01/28/1998 | EP0820466A2 Fluorescent peptides |
| 01/28/1998 | EP0820465A2 Bioprocess for production of dipeptide based compounds |
| 01/28/1998 | EP0820463A1 Igf-i purification process |
| 01/28/1998 | EP0820433A1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof |
| 01/28/1998 | EP0820313A2 Radiolabeled peptides for diagnosis and therapy |
| 01/28/1998 | EP0820312A1 Ternary radiopharmaceutical complexes |
| 01/28/1998 | EP0820311A1 Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface |
| 01/28/1998 | EP0820308A2 Conjugate for treating inflammatory, infectious and/or skin diseases |
| 01/28/1998 | EP0820304A1 Chlamydia vaccines |
| 01/28/1998 | EP0820303A1 PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES |
| 01/28/1998 | EP0820296A1 Analogs of growth hormone-releasing factor |
| 01/28/1998 | EP0820295A1 Modified lysine or arginine containing proteins and peptides |
| 01/28/1998 | EP0820285A1 Methods and compositions for lipidization of hydrophilic molecules |
| 01/28/1998 | EP0820220A1 Transgenic tomato plants containing a fusarium resitance gene |
| 01/28/1998 | EP0752886B1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| 01/28/1998 | EP0474789B1 Cysteine thiol-protected peptides for use in immunoassays |
| 01/28/1998 | EP0422217B1 Human recombinant placental ribonuclease inhibitor and method of production |
| 01/28/1998 | CN1171822A Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them |
| 01/28/1998 | CN1171821A Transgenic plants expressing DNA constructs containing plurality of genes to impart virus resistance |
| 01/28/1998 | CN1171819A Method for secreting thrombopoietin polypeptides |
| 01/28/1998 | CN1171817A Genetic control of flowering |
| 01/28/1998 | CN1171816A CDNA encoding BMP type II receptor |
| 01/28/1998 | CN1171815A Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from fusion product in aspergillus |
| 01/28/1998 | CN1171814A Polynucleotide tuberculosis vaccine |
| 01/28/1998 | CN1171813A Delivery system |
| 01/28/1998 | CN1171791A Purified thrombopoietin and method of making it |
| 01/28/1998 | CN1171743A Novel tumor suppressor gene HIC-1 |
| 01/28/1998 | CN1171742A Selective acylation of epsilon-amino groups |
| 01/28/1998 | CN1171443A Frenolicin gene cluster |
| 01/28/1998 | CN1171400A Xantone compounds, their production and use |
| 01/27/1998 | US5712417 Inhibitors of retroviral proteases |
| 01/27/1998 | US5712395 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 01/27/1998 | US5712381 MADD, a TNF receptor death domain ligand protein |
| 01/27/1998 | US5712380 Angiogenesis inhibitor |
| 01/27/1998 | US5712375 Systematic evolution of ligands by exponential enrichment: tissue selex |
| 01/27/1998 | US5712372 Human thyroid hormone receptor |
| 01/27/1998 | US5712370 Erythropoietin (EPO) peptides and antibodies directed against these |
| 01/27/1998 | US5712369 Isolated protein which binds to A33 antibody, and peptides corresponding to portions of the protein |
| 01/27/1998 | US5712366 Fabrication of nanoscale materials using self-assembling proteins |
| 01/27/1998 | US5712258 Sustained release, orally active, purine compounds |
| 01/27/1998 | US5712249 Use of insulin-like growth factors I and II for inhibition of inflammatory response |
| 01/27/1998 | US5712248 From bacillus, toxin for lepidoptera |
| 01/27/1998 | US5712247 Use of lactoferrin to modulate and/or neutralize heparin activity |
| 01/27/1998 | US5712245 Protection against infection |
| 01/27/1998 | US5712160 From nerve growth factor receptor protein, applications to alzheimers*s disease and parkinson*s disease |
| 01/27/1998 | US5712158 Cell line for the rapid expression of functional calcium channels |